Home » FDA Clears New Parameter for Terumo’s Blood Monitor
FDA Clears New Parameter for Terumo’s Blood Monitor
The FDA granted clearance to Terumo Cardio’s CDI blood parameter monitoring system to monitor oxygen delivery in real-time.
The device is now approved to measure 12 critical blood parameters.
Measuring oxygen delivery is used during cardiopulmonary bypasses to help reduce acute kidney injury, a common complication of cardiac surgery.
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May